Detalhe da pesquisa
1.
Incidence and Predictors of Breakthrough and Severe Breakthrough Infections of SARS-CoV-2 After Primary Series Vaccination in Adults: A Population-Based Survey of 22 575 Participants.
J Infect Dis
; 227(10): 1164-1172, 2023 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729177
2.
Antibody Duration After Infection From SARS-CoV-2 in the Texas Coronavirus Antibody Response Survey.
J Infect Dis
; 227(2): 193-201, 2023 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35514141
3.
Comparison of Persistent Symptoms Following SARS-CoV-2 Infection by Antibody Status in Nonhospitalized Children and Adolescents.
Pediatr Infect Dis J
; 41(10): e409-e417, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35939608
4.
Applications and perspectives of nanomaterials in novel vaccine development.
Medchemcomm
; 9(2): 226-238, 2018 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30108916
5.
RE: Incidence of SARS-CoV-2 Breakthrough Infections After Vaccination in Adults: A Population-Based Survey Through 1 March 2023.
Open Forum Infect Dis
; 10(12): ofad564, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38099238